News

Expansion includes the centralized distribution of the H1N1 flu vaccine to as many as 90,000 sites across the U.S.

Acquisition extends Millipore’s biopharmaceutical services offering to European market.

Milestone triggered by MedImmune’s initiation of a phase I clinical trial of MEDI-547 for solid tumors.

License relates to the use of human isogenic cell-lines in predicting the response of drugs targeted at the genetic make-up of individual cancer patients.

febit’s HybSelect™ technology for sequence capture enables targeted Next-Generation Sequencing.

Company is actively seeking licensors or acquirers for its anti-parasitic drug discovery portfolio and cancer diagnostic platform.

Researchers show possibility to predict how different individuals would deal with one drug by looking at metabolites in their urine.

Company now plans for IND submissions with the FDA to include US patients in randomized, double-blinded lung cancer and brain metastases trials.

Scientists from the Indian Agricultural Research Institute were successful in creating the world's first transplastomic eggplant.

Scottish scientists are looking at how the most significant potato pathogen, Phytopthora infestans causes disease and identifying essential pathogen virulence genes that may be durable targets for host resistance proteins.